These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
510 related articles for article (PubMed ID: 33161397)
1. Is G-CSF Dangerous in COVID-19: Why Not Use GM-CSF? Lazarus HM; Gale RP Acta Haematol; 2021; 144(3):350-351. PubMed ID: 33161397 [No Abstract] [Full Text] [Related]
3. Cytokine-specific activation of distinct mitogen-activated protein kinase subtype cascades in human neutrophils stimulated by granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and tumor necrosis factor-alpha. Suzuki K; Hino M; Hato F; Tatsumi N; Kitagawa S Blood; 1999 Jan; 93(1):341-9. PubMed ID: 9864179 [TBL] [Abstract][Full Text] [Related]
4. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on lung cancer: roles of cyclooxygenase-2. Uemura Y; Kobayashi M; Nakata H; Kubota T; Saito T; Bandobashi K; Taguchi H Oncol Rep; 2007 Apr; 17(4):955-61. PubMed ID: 17342342 [TBL] [Abstract][Full Text] [Related]
5. Effect of serum deprivation on constitutive production of granulocyte-colony stimulating factor and granulocyte macrophage-colony stimulating factor in lung cancer cells. Uemura Y; Kobayashi M; Nakata H; Harada R; Kubota T; Taguchi H Int J Cancer; 2004 May; 109(6):826-32. PubMed ID: 15027115 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome. Papoff P; Christensen RD; Calhoun DA; Juul SE Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813 [TBL] [Abstract][Full Text] [Related]
7. Phase I/II study of combined granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor administration for the mobilization of hematopoietic progenitor cells. Winter JN; Lazarus HM; Rademaker A; Villa M; Mangan C; Tallman M; Jahnke L; Gordon L; Newman S; Byrd K; Cooper BW; Horvath N; Crum E; Stadtmauer EA; Conklin E; Bauman A; Martin J; Goolsby C; Gerson SL; Bender J; O'Gorman M J Clin Oncol; 1996 Jan; 14(1):277-86. PubMed ID: 8558209 [TBL] [Abstract][Full Text] [Related]
8. The requirement for granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in leukocyte-mediated immune glomerular injury. Kitching AR; Ru Huang X; Turner AL; Tipping PG; Dunn AR; Holdsworth SR J Am Soc Nephrol; 2002 Feb; 13(2):350-358. PubMed ID: 11805162 [TBL] [Abstract][Full Text] [Related]
9. G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome. Aggarwal A; Baker CS; Evans TW; Haslam PL Eur Respir J; 2000 May; 15(5):895-901. PubMed ID: 10853855 [TBL] [Abstract][Full Text] [Related]
10. Electronegative L5-LDL induces the production of G-CSF and GM-CSF in human macrophages through LOX-1 involving NF-κB and ERK2 activation. Yang TC; Chang PY; Kuo TL; Lu SC Atherosclerosis; 2017 Dec; 267():1-9. PubMed ID: 29078142 [TBL] [Abstract][Full Text] [Related]
11. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066 [TBL] [Abstract][Full Text] [Related]
13. Effects of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor on glial scar formation after spinal cord injury in rats. Chung J; Kim MH; Yoon YJ; Kim KH; Park SR; Choi BH J Neurosurg Spine; 2014 Dec; 21(6):966-73. PubMed ID: 25279652 [TBL] [Abstract][Full Text] [Related]
14. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. Biethahn S; Alves F; Wilde S; Hiddemann W; Spiekermann K Exp Hematol; 1999 May; 27(5):885-94. PubMed ID: 10340405 [TBL] [Abstract][Full Text] [Related]
15. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma. Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669 [TBL] [Abstract][Full Text] [Related]
16. Granulocyte colony-stimulating factor, not granulocyte-macrophage colony-stimulating factor, co-operates with retinoic acid on the induction of functional N-formyl-methionyl-phenylalanine receptors in HL-60 cells. Sakashita A; Nakamaki T; Tsuruoka N; Honma Y; Hozumi M Leukemia; 1991 Jan; 5(1):26-31. PubMed ID: 1705636 [TBL] [Abstract][Full Text] [Related]
17. Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Peters WP; Rosner G; Ross M; Vredenburgh J; Meisenberg B; Gilbert C; Kurtzberg J Blood; 1993 Apr; 81(7):1709-19. PubMed ID: 7681699 [TBL] [Abstract][Full Text] [Related]
18. Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis. Kojima K; Nakashima F; Boku A; Muroishi Y; Nakanishi I; Oda Y Histol Histopathol; 2002 Oct; 17(4):1005-16. PubMed ID: 12371127 [TBL] [Abstract][Full Text] [Related]
19. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies. Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099 [TBL] [Abstract][Full Text] [Related]
20. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function. Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]